Time for an update on the performance of my ARF for the first six months of 2024.
As regular readers know, my investment strategy is simple: invest close to 100% in shares and keep transaction costs to a minimum. It's the same as the strategy I advocated for my ill-fated auto-enrolment proposal.
I achieved both goals in the six months to end June. For every €100,000 of fund value at end 2023, there was just €623 cash; the other €99,377 was in shares. Sales in the six months were €2,003 (to cover pension withdrawals of €2,968); there were no purchases. Unfortunately, there is no escaping ARF manager’s fees, which are excessive in Ireland, but I negotiated a reduction from the start of 2024. Total fees for the half-year, including sales commission, were €246 (all figures are per €100,000 of fund value at the start of the year). Cash in the fund increased to €1,955 at 30 June on the back of dividend receipts. The fund’s value increased to €110,243 and the return for the half-year was 13.4%.
The six-month return was good but short-term returns should neither excite nor worry the long-term investor. (They do, though, despite our best efforts!) What matters is the long-term. I have been tracking the return on the ARF since I “retired” at end 2010. A number of milestones were reached in the first half of 2024. Total pension withdrawals in the thirteen and a half years to 30 June 2024 exceeded the amount invested at the start and the fund’s value increased to more than double the initial investment. The average return for the entire period was 11.2%.
I don’t claim any investment expertise, but I like to hold individual shares rather than units in unit-linked funds. It gives me a greater sense of security to see the fund invested in real businesses. I also save on investment managers’ fees: the average fund manager doesn’t add value and I don’t have the expertise to identify the few exceptions. I take the simple (simplistic?) view that the market is good at pricing shares relative to one another, since at any time there’s an equal weight of investors wanting to buy a share at a given price as there are people wanting to sell at that price, so the performance of a portfolio assembled at random won’t diverge much from the market average in the long-term.
I have tracked returns on shares that have been in my ARF for the three-an-a-half years from 31 December 2020 to 30 June 2024. There have been startling differences in performance. The winner by a country mile was Novo Nordisk, the Danish pharma company, whose share price at end June 2024 (allowing for a 2 for 1 split) was almost five times what it was at end 2020. I first wrote about it back in 2019 in my blog
here. Thankfully, I held on to all the shares I had at the start of the period and so have benefited from the full rise in the share price. The problem now is that Novo Nordisk accounts for a very high percentage of my fund.
The second-best performer came as a surprise when I did the sums, but it made sense on further reflection. Town Centre Securities is a UK regional property company. It has been in my ARF for at least ten years. Its share price was on the floor in 2020 but it has since staged a remarkable recovery. By 30 June 2024, its value was almost four times its value at end 2020. It also paid a dividend for the entire period.
The worst performer was Disney Company: its value (in Euros) at end June 2024 was less than two-thirds its end 2020 value. To add insult to injury, it didn’t pay a dividend. (Correction: there was a small dividend in January 2024, after a four-year hiatus)
My biggest single investment, Phoenix Group Holdings, also performed indifferently: its market value fell by more than 20% in the period, but there was the consolation of excellent dividends. The dividend has increased consistently, yet the dividend yield at 30 June was over 10%.
Looking forward, with advancing age comes a greater degree of caution, so I may shift the balance of the portfolio towards more defensive stocks. That could mean selling some of my Novo Nordisk holding. Overall, though, the strategy of staying invested in equities and keeping transaction costs to a minimum will remain unchanged.